Masahiko Tomiyama

Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats

Hiroyasu Tanaka, Kazuya Kannari, Tetsuya Maeda et al. · Neuroreport · 1999 · 300 citations

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik, Vera Bril, Nan van Geloven et al. · The Lancet Neurology · 2017 · 258 citations · Full text

Subcutaneous Immunoglobulin, Autoimmune Disease, Chronic Inflammatory +12

Activation of 5‐HT_1A but not 5‐HT_1B receptors attenuates an increase in extracellular dopamine derived from exogenously administered <scp>l</scp>‐DOPA in the striatum with nigrostriatal denervation

Kazuya Kannari, Hiroshi Yamato, Huo Shen et al. · Journal of Neurochemistry · 2001 · 133 citations · Full text

Synaptic Transmission, Nigrostriatal Denervation, L-dopa Injection +22

Clinical availability of skin biopsy in the diagnosis of Parkinson's disease

Yasuo Miki, Masahiko Tomiyama, Tatsuya Ueno et al. · Neuroscience Letters · 2009 · 112 citations

Clinical Availability, Parkinson Disease, Diagnosis +7

[Tandospirone citrate, a selective 5-HT1A agonist, alleviates L-DOPA-induced dyskinesia in patients with Parkinson's disease].

Kazuya Kannari, Kozo Kurahashi, Masahiko Tomiyama et al. · PubMed · 2002 · 96 citations

Selective 5-Ht1a Agonist, L-dopa Administration, Excessive Increase +13